Novartis and Incyte’s Jakafi has had a whirlwind few weeks as it rolls into a late-stage trial as […]
Category: Uncategorized
“Deep breath in … and out. Again, deep breath in … and out.”We tune in to patients’ breath […]
The European Medicines Agency’s pharmacovigilance risk assessment committee (PRAC) has recommended updating the product information for drugs containing […]
The recent publication of an industry sponsored, open, non-randomised study of remdesivir in a heterogeneous patient population has […]
An inquiry into childbirth cases of “serious and potentially serious concern” at Shrewsbury and Telford Hospitals NHS Trust […]
With a major Indian production hub now locked down in a COVID-19 containment zone, the spotlight on pharma’s […]
SVBLeerink analysts had expected sales of Pfizer’s hot new drug Vyndaqel to treat ATTR cardiomyopathy to come in […]
Biogen may be the biopharma company whose employees have been most intimately affected by the COVID-19 pandemic. Aside from dozens […]
The formulations can be prepared quickly and easily by pharmacies and help alleviate the current shortage of disinfectants.